What is the recommended management for an adult with a PHQ‑9 total score of 6 (mild depression)?

Management of PHQ-9 Score of 6 (Mild Depression)

For an adult with a PHQ-9 score of 6, no formal treatment intervention is required, but supportive care services, education, and close monitoring should be provided. 1

Risk Stratification and Initial Assessment

A PHQ-9 score of 6 falls within the none/mild symptomatology range (score 1-7), which indicates:

• No or minimal symptoms of depression 1
• Effective coping skills and access to social support are typically present 1
• No functional impairment or only minimal impact on daily activities 1

However, you must first assess for any risk of harm to self or others - if present, immediate referral for emergency evaluation by a licensed mental health professional is required regardless of the PHQ-9 score. 1

Identify Risk Factors for Progression

Even with mild symptoms, assess pertinent history and specific risk factors that may warrant closer monitoring: 1

• Prior mood disorder with or without prior treatment
• History of comorbid mood and/or anxiety disorders (e.g., GAD)
• Prior or current substance use
• Presence of other chronic illnesses (e.g., coronary heart disease, COPD)
• Recurrent, advanced, or progressive disease (in cancer patients)
• Social isolation (single, not married, widowed, divorced vs. partnered)
• Unemployment with or without low financial resources
• Lower education level (less than high school/GED)

Recommended Management Approach

Supportive Care Services (Primary Intervention)

Provide education and information (verbal plus relevant materials) for the patient and family about: 1

• Normalcy of stress in various life contexts
• Sources of informational support and resources
• Available community resources and support services
• Self-care strategies and healthy lifestyle behaviors

Low-Intensity Interventions (Optional but Beneficial)

While not mandatory at this severity level, consider offering referral to: 1

• Structured physical activity programs - exercise has demonstrated benefit even for mild symptoms 1
• Psychosocial group interventions - structured groups led by licensed mental health professionals covering stress reduction, positive coping (information seeking, problem-solving, assertive communication), and enhancing social support 1
• Individually guided self-help based on cognitive behavioral therapy (CBT), including behavioral activation and problem-solving 1

What NOT to Do

Pharmacologic treatment is NOT appropriate at this severity level (PHQ-9 score 1-7). 1 Antidepressants should be reserved for moderate to severe symptomatology (PHQ-9 ≥8).

Formal mental health referral is NOT required unless risk factors suggest higher vulnerability or symptoms worsen. 1

Follow-Up and Monitoring Strategy

Establish a monitoring schedule rather than active treatment: 1

• Re-screen at regular intervals using the PHQ-9 (timing depends on clinical context)
• For cancer patients specifically: screen at regular intervals during treatment, at 3,6, and 12 months after treatment, at diagnosis of recurrence or progression, and during times of personal transition or family crisis 1
• For general primary care: consider re-screening if clinical circumstances change or new stressors emerge 1

Escalate care if symptoms worsen: If subsequent PHQ-9 scores reach ≥8, then formal evaluation and treatment interventions become indicated. 1

Important Clinical Caveats

• The PHQ-9 score represents screening results, not a clinical diagnosis - it identifies symptom severity but does not diagnose major depressive disorder. 1
• Consider special circumstances: Use culturally sensitive assessments when possible, tailor approaches for those with learning disabilities or cognitive impairments, and be aware of the difficulty detecting depression in older adults. 1
• Medical causes must be excluded: Treat any underlying medical causes of depressive symptoms (e.g., unrelieved pain, fatigue) and rule out delirium before attributing symptoms to depression. 1
• The cutoff of 8 (not 10) is recommended for identifying clinically significant depression requiring intervention, based on validation studies in various populations. 1